Max Healthcare rises over 5% as Q2 PAT shoots up 147% YoY
The company said growth in Q2FY23 revenue and operating EBITDA were driven by higher occupancies, improved payor mix and increased ARR in the outpatient department. International patient revenue grew 16% YoY and reflected 110% of the pre-Covid average.
